Rhoda Au
Boston University
Framingham Heart StudyOffspringFramingham Risk ScoreInternal medicineNeuropsychologyHyperintensityPsychologyCardiologyCognitionCohort studyDiseaseDementiaPopulationCognitive declineAlzheimer's diseaseRisk factorStrokeMedicineCohortGerontology
Publications 286
#1Erin Smith (Stanford University)H-Index: 1
Last. Harris A. Eyre (Deakin University)H-Index: 16
view all 33 authors...
#1Jing Yuan (BU: Boston University)
#2Nancy N. Maserejian (Biogen Idec)H-Index: 23
Last. Rhoda AuH-Index: 63
view all 7 authors...
Background Studies providing Alzheimer's disease (AD) prevalence data have largely neglected to characterize the proportion of AD that is mild, moderate, or severe. Estimates of the severity distribution along the AD continuum, including the mild cognitive impairment (MCI) stage, are important to plan research and allocate future resources, particularly resources targeted at particular stages of disease. Objective To characterize the distribution of severity of AD dementia and MCI among prevalen...
#1Rhoda Au (BU: Boston University)H-Index: 63
#2Kieffer Christianson (BU: Boston University)
Last. Cody Karjadi (BU: Boston University)H-Index: 1
view all 5 authors...
#1Sheina Emrani (Rowan University)H-Index: 3
#2Satya Baliga (Johns Hopkins University)
Last. David J. Libon (Rowan University)H-Index: 43
view all 10 authors...
#1Xiaoling Zhang (BU: Boston University)H-Index: 52
#2Tong Tong (BU: Boston University)
Last. Lindsay A. Farrer (BU: Boston University)H-Index: 92
view all 13 authors...
#1Rebecca Panitch (BU: Boston University)
#2Hu J (BU: Boston University)
Last. Gyungah Jun (BU: Boston University)H-Index: 33
view all 13 authors...
#1Gyungah Jun (BU: Boston University)H-Index: 33
Last. Lindsay A. FarrerH-Index: 92
view all 20 authors...
#1Michael A. Sugarman (Edith Nourse Rogers Memorial Veterans Hospital)H-Index: 13
#2Henrik Zetterberg (UCL Institute of Neurology)H-Index: 104
Last. Michael L. Alosco (BU: Boston University)H-Index: 33
view all 20 authors...
Abstract We examined baseline and longitudinal associations between plasma neurofilament light (NfL) and total tau (t-tau), and the clinical presentation of Alzheimer’s disease (AD). 579 participants (238, normal cognition [NC]; 185, mild cognitive impairment [MCI]; 156, AD dementia) had baseline blood draws; 82% had follow-up evaluations. Plasma samples were analyzed for NfL and t-tau using Simoa technology. Baseline plasma NfL was higher in AD dementia compared to MCI (standardized mean differ...
3 CitationsSource
Close Researchers